Concepedia

Author

Hiroaki Toshimitsu

Yamaguchi University

Also Known As

H Toshimitsu, H. Toshimitsu, Hiroaki TOSHIMITSU, Hiroaki Toshimitsu

43

Publications

257

Citations

7

H-Index

14

Concepts

All Affiliations

Yamaguchi UniversityDurham VA Medical CenterDuke University HospitalDuke UniversityDuke Medical Center
HT

About

Hiroaki Toshimitsu is an author at Yamaguchi University specializing in oncology, cancer research, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

104

2

Pathology

3

3

104

3

Cell Biology

2

2

85

4

Cancer Genetics

1

1

38

5

Cancer Therapeutics

1

1

19

Hiroaki Toshimitsu

×

6

Publications

224

Citations

6

H-Index

YearCitations

Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit Melanoma

Ryan S. Turley, Andrew N. Fontanella, James C. Padussis,

Clinical Cancer Research

2012

57

Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells

Hiroaki Toshimitsu, Kiichiro Hashimoto, Akira Tangoku,

Cancer Letters

2004

47

Sorafenib, a Multikinase Inhibitor, Enhances the Response of Melanoma to Regional Chemotherapy

Christina K. Augustine, Hiroaki Toshimitsu, Sin‐Ho Jung,

Molecular Cancer Therapeutics

2010

45

Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma.

Takashi Ueno, Akira Tangoku, Shigefumi Yoshino,

PubMed

2002

38

Inhibition of Poly(ADP-Ribose) Polymerase Enhances the Effect of Chemotherapy in an Animal Model of Regional Therapy for the Treatment of Advanced Extremity Malignant Melanoma

Hiroaki Toshimitsu, Yasunori Yoshimoto, Christina K. Augustine,

Annals of Surgical Oncology

2010

19

Targeting N-cadherin Increases Vascular Permeability and Differentially Activates AKT in Melanoma

Ryan S. Turley, Yoshihiro Tokuhisa, Hiroaki Toshimitsu,

Annals of Surgery

2014

18

Page 1